The presence of a bulky mediastinal mass of 7 cm or greater in diameter confers an adverse prognosis to patients with advanced Hodgkin lymphoma in case of negative interim PET/CT Journal Article


Authors: Lopez-Alonso, R.; Qi, S.; Mashiach, T.; Weiler-Sagie, M.; Yahalom, J.; Dann, E. J.
Article Title: The presence of a bulky mediastinal mass of 7 cm or greater in diameter confers an adverse prognosis to patients with advanced Hodgkin lymphoma in case of negative interim PET/CT
Abstract: In the PET-adapted therapy era, a bulky mediastinal mass (BMM) is not considered a risk factor in patients with advanced-stage Hodgkin lymphoma (HL). The current retrospective study aimed to estimate the prognostic significance of BMM presence and size for disease-free survival (DFS) and determine the most accurate mass size cutoff (among 5 cm, 7 cm, 10 cm) to predict inferior DFS in such patients. The study included 196 advanced-HL patients treated at Rambam (n = 121) and Memorial Sloan Kettering Cancer Center (n = 75) between 2002 and 2016. At a median follow-up of 66.5 (1–222) months, 36 relapses occurred. In multivariate analysis, only the cutoff of 7 cm predicted inferior DFS and PFS (p < 0.007 and <0.038, respectively) in interim PET/CT (PET-2) negative (79%) patients. This study identifies the BMM size cutoff of 7 cm in any plane as most precise in predicting adverse prognosis in PET-2-negative patients with advanced-stage HL. More aggressive initial chemotherapy than ABVD improves such prognosis. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
Keywords: disease-free survival; a bulky mediastinal mass; advanced-stage hodgkin lymphoma; interim pet/ct (pet-2)
Journal Title: Leukemia and Lymphoma
Volume: 62
Issue: 6
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2021-01-01
Start Page: 1313
End Page: 1324
Language: English
DOI: 10.1080/10428194.2021.1872069
PUBMED: 33478289
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 July 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joachim Yahalom
    634 Yahalom
  2. Shunan Qi
    14 Qi